NFL Biosciences develops a naturally based addiction withdrawal solution to help smokers willing to quit in their battle for a healthier life. Based in France, this biotech company focused on commercializing NFL-101 a subcutaneous injection for smoking cessation. Traded on EuroNext ALNFL
